Positive list system never acceptable in KORUS FTA

Published: 2006-06-15 07:00:00

Updated: 2006-06-15 07:00:00

In the FTA talk meeting between Korea and the United States called KORUS FTA, the United States side had kept a firm stance for the positive list system, a drug pricing policy actively promoted by the MOHW of Korea, not to be acceptable, raising interests to see how this issue may go in the futur...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK